Governing Accountability in China's Life Sciences: A Comparative Study of Stem Cell and GM Food Governance
中国生命科学的治理问责:干细胞与转基因食品治理的比较研究
基本信息
- 批准号:ES/L009803/1
- 负责人:
- 金额:$ 29.58万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2015
- 资助国家:英国
- 起止时间:2015 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
China's rise as a 'leading influence' in the organization and delivery of scientific innovation is Janus-faced (FCO and BIS, 2013). On the one hand, China presents new opportunities of maximizing the uptake and application of science in a climate of sluggish economic growth. On the other hand, a persistent deficiency in ensuring responsible research conduct casts a shadow on the public attitude towards research conducted in, and with, China. Cases such as locally authorized stem cell therapy and unsupervised GM food trials not only has the effect of damaging China's own scientific reputation, but also impairs global public trust of biotechnologies (Moreno, 2010, Qiu, 2012).This project proposes a timely and ambitious study on the accountability problem in China's life science governance through a comparative study of stem cell research and GM foods. This draws on my extensive network and previous research in both fields. Through a combination of semi-structured interviews, focus groups and international workshops, this project engages with regulators, scientists and civil society actors in both China and the UK. It makes an important contribution to the co-production of alternative ways to address public accountability in the life sciences. The analytical focus will be on the following questions:RQ1: What are the regulatory standards and procedures used in defining, selecting and sustaining accountable research practice in stem cell research and GM foods in China? How are the development of the 'legitimation devices' shaped by domestic and international debates? RQ2: How are the power dynamics among scientists, regulators and bioethisists constructed in stem cell and GM food regulations? What are the similarities and differences in the legitimisation of research practice in both fields? RQ3: What forms of communication are needed to make stem cell and GM research more accessible to, and assessable by, the public? How can China improve its effective accountability to its potential research users and collaborators?Stem cell research and GM foods make for excellent case studies. They provide complementary views on the project's three core research questions. Stem cell and GM technologies are both highly visible and controversial fields in China, but they represent the opposite ends of risk framing. While China's GM food regulation consists of a 'strong precautionary element', China's stem cell regulation arguably resembles a 'proactionary' approach (Tiberghien, 2010; Zhang, 2012). Despite these differences, stem cell and GM technologies in China share a similar regulatory history and governing structure. Both are predominately regulated by the Ministry of Health, the China Food and Drug Authority and the Ministry of Science and Technology. This difference in regulatory rationales and overlap in governance structures will provide rich comparable data for the research questions.Addressing the accountability problem is not only crucial for China's goal of becoming a trusted player in the competitive and skeptical global community, but is also important for enabling efficient international collaborations and promoting research integrity in the life sciences. Thus, this research will be important to a number of non-academic users, such as 1) regulators and research funders in both China and Europe; 2) transnational scientific societies; 3) international civil society organisations, such as patient advocacy groups, environmental NGOs and 4) hospitals and biotechnology enterprises. Given the interdisciplinary nature this research, this project also enriches academic debates in a variety of disciplines, such as sociology, governance studies, bioethics, China studies and the life sciences.Planned outputs includes 1 academic monograph, 6 articles in science and social science journals, 1 policy report in both English and Chinese, 1 regularly updated project website for public audiences and 2 international workshops.
中国在组织和提供科学创新方面的“主导影响力”的崛起是双面的(FCO和BIS,2013)。一方面,中国在经济增长缓慢的情况下为最大限度地吸收和应用科学提供了新的机会。另一方面,在确保负责任的研究行为方面持续存在的不足给公众对在中国进行的研究以及与中国进行的研究的态度蒙上了阴影。地方授权的干细胞治疗和无监督的转基因食品试验等案例不仅损害了中国自身的科学声誉,也损害了全球公众对生物技术的信任(Moreno,2010,Qiu,2012)。本项目通过对干细胞研究和转基因食品的比较研究,提出了一项及时而雄心勃勃的研究,旨在探讨中国生命科学治理中的问责问题。这利用了我在这两个领域的广泛网络和以前的研究。通过半结构化访谈、焦点小组和国际研讨会的结合,该项目与中国和英国的监管机构、科学家和民间社会行为者进行了接触。它为共同制定解决生命科学领域公共问责问题的替代办法做出了重要贡献。分析重点将放在以下问题上:RQ 1:在中国干细胞研究和转基因食品的定义、选择和维持负责任的研究实践中使用了哪些监管标准和程序?国内和国际辩论如何塑造“合法化手段”的发展?在干细胞和转基因食品法规中,科学家、监管者和生物伦理学家之间的权力动态是如何构建的?在这两个领域中,研究实践的合法化有何异同?RQ 3:需要何种形式的沟通,使干细胞和转基因研究更容易获得,并评估,公众?中国如何提高对潜在研究用户和合作者的有效问责?干细胞研究和转基因食品是很好的案例研究。他们就该项目的三个核心研究问题提供了补充意见。在中国,干细胞和转基因技术都是备受关注和争议的领域,但它们代表了风险框架的两端。虽然中国的转基因食品监管包括一个“强有力的预防元素”,但中国的干细胞监管可以说类似于一个“主动”的方法(Tiberghien,2010; Zhang,2012)。尽管存在这些差异,但中国的干细胞和转基因技术有着相似的监管历史和管理结构。两者都主要由卫生部、中国食品药品监督管理局和科技部监管。这种监管理念的差异和治理结构的重叠将为研究问题提供丰富的可比数据。解决问责问题不仅对中国成为竞争激烈和充满怀疑的国际社会中值得信赖的参与者的目标至关重要,而且对实现有效的国际合作和促进生命科学研究的诚信也很重要。因此,这项研究对许多非学术用户非常重要,例如:1)中国和欧洲的监管机构和研究资助者; 2)跨国科学协会; 3)国际民间社会组织,如患者倡导组织,环境非政府组织和4)医院和生物技术企业。鉴于该研究的跨学科性质,该项目还丰富了社会学、治理研究、生物伦理学、中国研究和生命科学等多个学科的学术辩论,计划产出包括1本学术专著、6篇科学和社会科学期刊文章、1份中英文政策报告、1个定期更新的公众项目网站和2个国际研讨会。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comment: Transparency is a growth industry.
评论:透明度是一个成长型行业。
- DOI:10.1038/545s65a
- 发表时间:2017
- 期刊:
- 影响因子:64.8
- 作者:Zhang J
- 通讯作者:Zhang J
How to Be Modern? The Social Negotiation of 'Good Food' in Contemporary China.
如何成为现代?当代中国的“美食”的社会谈判。
- DOI:10.1177/0038038517737475
- 发表时间:2018-03
- 期刊:
- 影响因子:2.9
- 作者:Zhang JY
- 通讯作者:Zhang JY
Lost in translation? Accountability and governance of clinical stem cell research in China.
迷失在翻译中?
- DOI:10.2217/rme-2017-0035
- 发表时间:2017
- 期刊:
- 影响因子:2.7
- 作者:Zhang JY
- 通讯作者:Zhang JY
(Bio)politics of existence and social change: Insights from the Good Food Movement
存在和社会变革的(生物)政治:来自美食运动的见解
- DOI:10.1177/00380261211009069
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Zhang J
- 通讯作者:Zhang J
Public engagement: The next area of expansion in science
公众参与:科学的下一个扩展领域
- DOI:
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Joy Zhang
- 通讯作者:Joy Zhang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joy Zhang其他文献
Hypoxia and loss of emGCM1/em expression prevent differentiation and contact inhibition in human trophoblast stem cells
缺氧和GCM1表达缺失阻碍人滋养层干细胞的分化和接触抑制
- DOI:
10.1016/j.stemcr.2025.102481 - 发表时间:
2025-05-13 - 期刊:
- 影响因子:5.100
- 作者:
Jessica K. Cinkornpumin;Sin Young Kwon;Anna-Maria Prandstetter;Theresa Maxian;Jacinthe Sirois;James Goldberg;Joy Zhang;Deepak Saini;Purbasa Dasgupta;Mariyan J. Jeyarajah;Stephen J. Renaud;Soumen Paul;Sandra Haider;William A. Pastor - 通讯作者:
William A. Pastor
Editorial for MobiCASE 2011 Special Issue
- DOI:
10.1007/s11036-012-0429-4 - 发表时间:
2012-12-29 - 期刊:
- 影响因子:2.000
- 作者:
Joy Zhang;Jennifer L. Wong - 通讯作者:
Jennifer L. Wong
Integrity 2021: Integrity in Social Networks and Media
诚信 2021:社交网络和媒体的诚信
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Lluís Garcia Pueyo;Anand Bhaskar;R. V. Zwol;T. Sellis;G. Ranade;Prathyusha Senthil Kumar;Yu Sun;Joy Zhang - 通讯作者:
Joy Zhang
Dispensaries and Medical Marijuana Certifications and Indications: Unveiling the Geographic Connections in Pennsylvania, USA
药房和医用大麻认证和适应症:揭示美国宾夕法尼亚州的地理联系
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Annemarie G Hirsch;Eric A. Wright;C. Nordberg;Joseph Dewalle;E. L. Stains;A. Kennalley;Joy Zhang;Lorraine D. Tusing;Brian Piper - 通讯作者:
Brian Piper
Problem 7(a): Augmented Bergman complexes
问题 7(a):增强伯格曼复合体
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Elisabeth Bullock;Aidan Kelley;K. Ren;Gahl Shemy;Dawei Shen;Brian Y. Sun;Amy Tao;Joy Zhang - 通讯作者:
Joy Zhang
Joy Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Attribution of Machine-generated Code for Accountability
机器生成代码的责任归属
- 批准号:
DP240102164 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Discovery Projects
CRII: SaTC: Privacy vs. Accountability--Usable Deniability and Non-Repudiation for Encrypted Messaging Systems
CRII:SaTC:隐私与责任——加密消息系统的可用否认性和不可否认性
- 批准号:
2348181 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Global Governing Gaps and Accountability Traps for Solar Energy and Storage
太阳能和存储的全球治理差距和问责陷阱
- 批准号:
DP230103043 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Discovery Projects
Collaborative Research: U.S. institutions after COVID-19: Trust, accountability, and public perceptions
合作研究:COVID-19 后的美国机构:信任、责任和公众看法
- 批准号:
2422394 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
The Tipuna Project: Intergenerational Healing, Settler Accountability and Decolonising Participatory Action Research in Aotearoa
Tipuna 项目:新西兰的代际疗愈、定居者责任和非殖民化参与行动研究
- 批准号:
AH/X008223/1 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Research Grant
Collaborative Research: The Architecture of Accountability in 21st Century Latin America
合作研究:21 世纪拉丁美洲的问责架构
- 批准号:
2314749 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Conference: Understanding Democracy, Elections, and Political Accountability
会议:了解民主、选举和政治责任
- 批准号:
2321010 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Ethical Industry 4.0: Embedding Legality, Integrity and Accountability in Digital Manufacturing Ecosystems
道德工业 4.0:将合法性、诚信和责任融入数字制造生态系统
- 批准号:
2412678 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
CAREER: Integrating Trust and Accountability into Compliance Enforcement for a Secure Internet of Things
职业:将信任和问责融入安全物联网的合规执行中
- 批准号:
2237012 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant
Collaborative Research: SaTC: CORE: Small: Accountability for Central Bank Digital Currency
协作研究:SaTC:核心:小型:中央银行数字货币的责任
- 批准号:
2325477 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant